|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
|
US6232071B1
(en)
*
|
1990-06-11 |
2001-05-15 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
|
US6346611B1
(en)
*
|
1990-06-11 |
2002-02-12 |
Gilead Sciences, Inc. |
High affinity TGfβ nucleic acid ligands and inhibitors
|
|
US6762290B1
(en)
*
|
1999-07-29 |
2004-07-13 |
Gilead Sciences, Inc. |
High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors
|
|
AU782620B2
(en)
*
|
1991-06-10 |
2005-08-11 |
Gilead Sciences, Inc. |
High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors
|
|
US7087411B2
(en)
*
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
DK1198490T3
(da)
*
|
1999-07-14 |
2006-06-19 |
Alza Corp |
Neutral lipopolymer og liposomsammensætninger indeholdende samme
|
|
US7312325B2
(en)
*
|
2000-09-26 |
2007-12-25 |
Duke University |
RNA aptamers and methods for identifying the same
|
|
ATE469164T1
(de)
*
|
2001-10-26 |
2010-06-15 |
Noxxon Pharma Ag |
Modifizierte l-nukleinsäure
|
|
JP2005511576A
(ja)
*
|
2001-11-09 |
2005-04-28 |
アイテック・ファーマシューティカルズ |
眼球血管新生病を治療する方法
|
|
US7094410B2
(en)
*
|
2002-03-02 |
2006-08-22 |
The Scripps Research Institute |
DNA vaccine against proliferating endothelial cells and methods of use thereof
|
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
MXPA05000796A
(es)
*
|
2002-07-24 |
2005-04-19 |
Hoffmann La Roche |
Aditivos de acidos polialquilenglicolicos.
|
|
ATE516366T1
(de)
|
2002-07-25 |
2011-07-15 |
Archemix Corp |
Regulierte aptamer-therapeutika
|
|
US9303262B2
(en)
|
2002-09-17 |
2016-04-05 |
Archemix Llc |
Methods for identifying aptamer regulators
|
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
US8039443B2
(en)
|
2002-11-21 |
2011-10-18 |
Archemix Corporation |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
US10100316B2
(en)
|
2002-11-21 |
2018-10-16 |
Archemix Llc |
Aptamers comprising CPG motifs
|
|
AU2003297682A1
(en)
*
|
2002-12-03 |
2004-06-23 |
Archemix Corporation |
Method for in vitro selection of 2'-substituted nucleic acids
|
|
RU2234097C1
(ru)
*
|
2003-03-05 |
2004-08-10 |
Московский областной научно-исследовательский клинический институт |
Способ диагностики саркомы капоши
|
|
FR2852606A1
(fr)
*
|
2003-03-18 |
2004-09-24 |
Inst Nat Sante Rech Med |
Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
|
|
JP2007525177A
(ja)
|
2003-04-21 |
2007-09-06 |
アーケミックス コーポレイション |
血小板由来増殖因子に対する安定化アプタマーおよび腫瘍治療剤としてのそれらの使用
|
|
CL2004001996A1
(es)
*
|
2003-08-08 |
2005-05-06 |
Eyetech Pharmaceuticals Inc |
Aptameros anti-vegf (factor de crecimiento endotelial vascular) con bloqueo nucleotidico 5'-5' o 3'-3' invertido, composicion que lo contiene, util para trastornos de neovascularizacion.
|
|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
|
HUE038239T2
(hu)
|
2004-02-12 |
2018-10-29 |
Archemix Llc |
Komplementrendszerrel összefüggõ rendellenességek kezelésében alkalmazható aptamer terapeutikumok
|
|
US20050260153A1
(en)
*
|
2004-04-13 |
2005-11-24 |
Pericles Calias |
Facilitation of iontophoresis using charged moieties
|
|
US7579450B2
(en)
|
2004-04-26 |
2009-08-25 |
Archemix Corp. |
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
|
|
US7566701B2
(en)
|
2004-09-07 |
2009-07-28 |
Archemix Corp. |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
|
|
KR20070101226A
(ko)
|
2004-09-07 |
2007-10-16 |
아케믹스 코포레이션 |
앱타머의 약화학
|
|
EP2436391A3
(en)
|
2004-11-02 |
2012-07-04 |
Archemix LLC |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
CA2613442C
(en)
|
2005-06-30 |
2016-08-23 |
Archemix Corp. |
Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
|
|
EP1912676A2
(en)
*
|
2005-07-28 |
2008-04-23 |
(Osi) Eyetech, Inc. |
Cyclitol linker polymer conjugate
|
|
CN101304748A
(zh)
|
2005-08-22 |
2008-11-12 |
加利福尼亚大学董事会 |
Tlr激动剂
|
|
KR100877824B1
(ko)
|
2005-11-11 |
2009-01-12 |
한국생명공학연구원 |
Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
|
|
AU2006323412A1
(en)
*
|
2005-12-06 |
2007-06-14 |
Domantis Limited |
Ligands that have binding specificity for EGFR and/or VEGF and methods of use therefor
|
|
AU2006325030B2
(en)
*
|
2005-12-16 |
2012-07-26 |
Cellectis |
Cell penetrating peptide conjugates for delivering nucleic acids into cells
|
|
EP1970078A4
(en)
*
|
2006-01-11 |
2010-11-17 |
Kyowa Hakko Kirin Co Ltd |
COMPOSITION FOR INHIBITING A TARGET GENE IN AN EYEBORN AND REMEDY FOR ACAPIC DISEASE
|
|
NZ571791A
(en)
|
2006-03-08 |
2012-03-30 |
Archemix Llc |
Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders
|
|
CN101790380B
(zh)
*
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
|
US20110229498A1
(en)
|
2008-05-08 |
2011-09-22 |
The Johns Hopkins University |
Compositions and methods for modulating an immune response
|
|
ES2600781T3
(es)
*
|
2008-12-04 |
2017-02-10 |
Curna, Inc. |
Tratamiento para enfermedades relacionadas con el factor de crecimiento del endotelio vascular (vegf) mediante la inhibición de transcritos antisentido naturales de vegf
|
|
US8460696B2
(en)
|
2009-03-20 |
2013-06-11 |
Egen, Inc. |
Polyamine derivatives
|
|
US20120295811A1
(en)
|
2009-11-23 |
2012-11-22 |
Jean-Jacques Toulme |
Aptamers directed against the matrix protein-1 of type a influenza viruses and uses thereof
|
|
AR081361A1
(es)
|
2010-04-30 |
2012-08-29 |
Molecular Partners Ag |
Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
|
|
EP2618846A1
(en)
*
|
2010-09-24 |
2013-07-31 |
Mallinckrodt LLC |
Aptamer conjugates for targeting of therapeutic and/or diagnostic nanocarriers
|
|
EP2836597A1
(en)
|
2012-04-11 |
2015-02-18 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof
|
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
|
EP4170031A1
(en)
|
2012-10-23 |
2023-04-26 |
Caris Science, Inc. |
Aptamers and uses thereof
|
|
AU2013361323B2
(en)
|
2012-12-19 |
2018-09-06 |
Caris Science, Inc. |
Compositions and methods for aptamer screening
|
|
KR101807590B1
(ko)
|
2013-03-22 |
2017-12-11 |
고쿠리츠다이가쿠호징 도쿄다이가쿠 |
Il-17에 대한 앱타머 및 그 사용
|
|
DK4374873T3
(da)
|
2013-07-12 |
2025-11-03 |
Astellas Us Llc |
Middel til brug ved behandling eller forebyggelse af oftalmologiske tilstande
|
|
CN105980615A
(zh)
|
2013-08-28 |
2016-09-28 |
卡里斯生命科学瑞士控股有限公司 |
寡核苷酸探针及其用途
|
|
CN114306575A
(zh)
|
2014-12-11 |
2022-04-12 |
拜耳医药保健有限责任公司 |
具有小的活动性脉络膜新生血管病变的年龄相关性黄斑变性的治疗
|
|
BR112017014090A2
(pt)
|
2014-12-29 |
2018-03-06 |
Bonac Corporation |
composição, e, métodos para produção de uma composição e estabilização de uma molécula de ácido nucleico.
|
|
WO2016145128A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
|
EP3314027A4
(en)
|
2015-06-29 |
2019-07-03 |
Caris Science, Inc. |
THERAPEUTIC OLIGONUCLEOTIDES
|
|
US10941176B2
(en)
|
2015-07-28 |
2021-03-09 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
|
WO2017046140A1
(en)
|
2015-09-18 |
2017-03-23 |
Bayer Pharma Aktiengesellschaft |
Treatment regimens for dr and rvo in dependence of the extent of retinal ischemia
|
|
US10731166B2
(en)
|
2016-03-18 |
2020-08-04 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
|
WO2017205686A1
(en)
|
2016-05-25 |
2017-11-30 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
|
EP3332812A1
(en)
|
2016-12-07 |
2018-06-13 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Nucleic acid-based assembly and use of the assembly in cancer therapy
|
|
TW201904610A
(zh)
|
2017-06-14 |
2019-02-01 |
德商拜耳製藥公司 |
用於治療新生血管型青光眼之非抗體vegf拮抗劑
|
|
EP3650045B1
(en)
|
2017-07-04 |
2024-11-13 |
Daiichi Sankyo Company, Limited |
Drug for retinal degenerative disease associated with photoreceptor degeneration
|
|
WO2019210097A1
(en)
*
|
2018-04-25 |
2019-10-31 |
Vitrisa Therapeutics, Inc. |
Aptamers with stability, potency or half-life for enhanced safety and efficacy
|
|
GB202405551D0
(en)
|
2024-04-19 |
2024-06-05 |
Vvb Bio Pte Ltd |
Combination treatment
|